This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Commentary

Grow the Market

Alan J. Gelenberg

Published: August 1, 2001

Article Abstract
Commentary:

A few years ago, I was in a small group making a presentation to pharmaceutical executives. Their company manufactured a medication that dominated a psychiatric market. Several academic psychiatrists proposed a program to enhance recognition of that disorder and raise overall medication adherence.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 62

Quick Links: Journal

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived...

Read More...